Advertisement

Topics

Achillion Pharmaceuticals Company Profile

23:11 EST 24th November 2017 | BioPortfolio

Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, with a particular emphasis on antiviral drugs to treat diseases caused by hepatitis B and C viruses (HBV and HCV), HIV and herpes viruses.

Product Candidate Portfolio

The Company’s broad drug development pipeline includes antiviral compounds licensed from Yale University as well as those developed using our proprietary Zinc Finger Targeting (ZFT) technology. Achillion focuses on developing drugs to treat diseases caused by:



• Human immunodeficiency virus (HIV)

• Hepatitis B virus (HBV)

• Hepatitis C virus (HCV) • Herpes viruses

• Bacteria

• Fungi

Location

300 George Street
New Haven
06511
United States of America

Contact

Phone: (203) 624 7000
Fax: (203) 624 7003
Email: keastwood@achillion.com


News Articles [493 Associated News Articles listed on BioPortfolio]

-$0.18 EPS Expected for Achillion Pharmaceuticals, Inc. (ACHN) This Quarter

Wall Street brokerages expect Achillion Pharmaceuticals, Inc. to announce earnings per share of for the current quarter, Zacks reports. Zero analysts have provided estimates for Achillion Pharmaceutic...

-$0.15 EPS Expected for Achillion Pharmaceuticals, Inc. (ACHN) This Quarter

Equities analysts expect that Achillion Pharmaceuticals, Inc. will post earnings of per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Achillio...

ACHTUNG Kurseinbruch bei Achillion Pharmaceuticals-Aktie! - Aktiennews

Bad Marienberg - +++ ACHTUNG +++ Kurseinbruch bei Achillion Pharmaceuticals-Aktie! - Aktiennews Achillion Pharmaceuticals-Aktienanalyse des Analysten Brian Skorney von Robert W. Baird: Der Aktienku...

Zacks: Brokerages Expect Achillion Pharmaceuticals, Inc. (ACHN) to Post -$0.18 EPS

Brokerages forecast that Achillion Pharmaceuticals, Inc. will post earnings per share for the current quarter, according to Zacks . Zero analysts have made estimates for Achillion Pharmaceuticals'...

Achillion Pharmaceuticals (ACHN) - Termination of coverage

Edison Investment Research - Pharmaceutical & healthcare - Achillion Pharmaceuticals: Edison Investment Research is terminating coverage on Achillion Pharmaceuticals (ACHN). Please note you should no ...

Analysts Expect Achillion Pharmaceuticals, Inc. (ACHN) Will Announce Earnings of -$0.16 Per Share

Brokerages expect that Achillion Pharmaceuticals, Inc. will post earnings of per share for the current quarter, according to Zacks Investment Research . Zero analysts have provided estimates for Achil...

Why Achillion Pharmaceuticals Is Shooting 25% Higher Today

After the company updated investors on its second-quarter financials and the progress it's making in its clinical-stage drug pipeline, shares in Achillion Pharmaceuticals in 2015, Achillion Pharma...

J&J backs out of $1.1 billion hep C deal, wiping 22.2% from Achillion's stock

Johnson & Johnson has announced that it is to back out of a $1.1 billion deal with Achillion Pharmaceuticals to develop the firm’s hepatitis C drug pipeline. The news sent Achillion’s stock re...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [119 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [208 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1290 Associated Companies listed on BioPortfolio]

Achillion

Achillion is an innovative pharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. The Company’s discovery and development teams have advanced mult...

Achillion Pharmaceuticals

Achillion is a privately held pharmaceutical company focused on the discovery, development and commercialization of innovative small molecule drugs that combat drug resistance in infectious diseases, ...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

More Information about "Achillion Pharmaceuticals" on BioPortfolio

We have published hundreds of Achillion Pharmaceuticals news stories on BioPortfolio along with dozens of Achillion Pharmaceuticals Clinical Trials and PubMed Articles about Achillion Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Achillion Pharmaceuticals Companies in our database. You can also find out about relevant Achillion Pharmaceuticals Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record